Legere Lavendar Foot Patch
Topical Starch
Myriad Co., Ltd.
Human Otc Drug
NDC 82504-104Legere Lavendar Foot Patch also known as Topical Starch is a human otc drug labeled by 'Myriad Co., Ltd.'. National Drug Code (NDC) number for Legere Lavendar Foot Patch is 82504-104. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Legere Lavendar Foot Patch drug includes Starch, Corn - 31.92 g/100g . The currest status of Legere Lavendar Foot Patch drug is Active.
Drug Information:
| Drug NDC: | 82504-104 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Legere Lavendar Foot Patch |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Topical Starch |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Myriad Co., Ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Patch |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | STARCH, CORN - 31.92 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 10 Jan, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 04 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Myriad Co., Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | O8232NY3SJ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 82504-104-01 | 40 g in 1 BOX (82504-104-01) | 10 Jan, 2022 | N/A | Yes |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose skin protectant
Product Elements:
Legere lavendar foot patch topical starch lavender oil pyroligneous acid eriobotrya japonica leaf perlite ascorbic acid eucalyptus oil poliglusam ethylhexylglycerin starch, corn starch, corn artemisia princeps leaf silicon dioxide glyceryl caprylate schorl tourmaline sorbitol
Indications and Usage:
Directions adults and children 4 years of age and over: step 1: clean and dry area for the patch to be attached. step 2: remove the protective cover sheet and gently apply. step 3: leave it on at least 4hours before remove. children under 4years of age: consult with a doctor.
Warnings:
Warnings for external use only / donât eat or swallow it
Do Not Use:
Warnings for external use only / donât eat or swallow it
When Using:
When using this product â do not use otherwise than directed. â do not stretch out the adhesive tape. â do not take out the contents from the patch. â if the patch has been ripped, discard it immediately.
Dosage and Administration:
Uses may help relieve minor aches and pain
Stop Use:
Stop use and ask a doctor if â if allergic reaction or irritation occurs â if you are pregnant, nursing or under medial treatment
Package Label Principal Display Panel:
Légère lavender foot patch 82504-104-01 82504